[go: up one dir, main page]

ES2013431A6 - PROCEDURE FOR PREPARING SOMATOSTATINE PEPTIDES. - Google Patents

PROCEDURE FOR PREPARING SOMATOSTATINE PEPTIDES.

Info

Publication number
ES2013431A6
ES2013431A6 ES8901255A ES8901255A ES2013431A6 ES 2013431 A6 ES2013431 A6 ES 2013431A6 ES 8901255 A ES8901255 A ES 8901255A ES 8901255 A ES8901255 A ES 8901255A ES 2013431 A6 ES2013431 A6 ES 2013431A6
Authority
ES
Spain
Prior art keywords
peptides
procedure
preparing
somatostatine
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8901255A
Other languages
Spanish (es)
Inventor
Rainer Albert
Wilfried Bauer
Francois Cardinaux
Janos Pless
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808442A external-priority patent/GB8808442D0/en
Priority claimed from GB888826452A external-priority patent/GB8826452D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2013431A6 publication Critical patent/ES2013431A6/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR PEPTIDOS DE SOMATOSTATINA QUE COMPRENDEN AL MENOS UN RESIDUO DE FORMULA (A), (B) O (C): EN DONDE LOS RADICALES TIENEN LOS SIGNIFICADOS DADOS EN LA DESCRIPCION. COMPRENDE, ENTRE OTRAS SINTESIS, AMINAR REDUCTIVAMENTE UN COMPUESTO DE FORMULA (III) O (IV) CON UN COMPUESTO DE FORMULA P-NH2 EN DONDE P ES UN RESIDUO PEPTIDO DE SOMATOSTATINA EN FORMA PROTEGIDA. LOS PEPTIDOS DE SOMATOSTATINA SON MEDICAMENTOS QUE TIENEN ACTIVIDAD INHIBIDORA DE LA HORMONA DE CRECIMIENTO.PROCEDURE FOR PREPARING SOMATOSTATIN PEPTIDES THAT COMPRISE AT LEAST ONE RESIDUE OF FORMULA (A), (B) OR (C): WHERE THE RADICALS HAVE THE MEANINGS GIVEN IN THE DESCRIPTION. IT INCLUDES, AMONG OTHER SYNTHESIS, REDUCTIVELY AMINATE A COMPOUND OF FORMULA (III) OR (IV) WITH A COMPOUND OF FORMULA P-NH2 WHERE P IS A SOMATOSTATIN PEPTIDE RESIDUE IN PROTECTED FORM. SOMATOSTATIN PEPTIDES ARE DRUGS THAT HAVE GROWTH HORMONE INHIBITOR ACTIVITY.

ES8901255A 1988-04-11 1989-04-11 PROCEDURE FOR PREPARING SOMATOSTATINE PEPTIDES. Expired - Lifetime ES2013431A6 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808442A GB8808442D0 (en) 1988-04-11 1988-04-11 Peptide derivatives
GB888826452A GB8826452D0 (en) 1988-11-11 1988-11-11 Peptide derivatives

Publications (1)

Publication Number Publication Date
ES2013431A6 true ES2013431A6 (en) 1990-05-01

Family

ID=26293760

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8901255A Expired - Lifetime ES2013431A6 (en) 1988-04-11 1989-04-11 PROCEDURE FOR PREPARING SOMATOSTATINE PEPTIDES.

Country Status (14)

Country Link
JP (1) JPH01305098A (en)
AU (1) AU3263989A (en)
BE (1) BE1003200A4 (en)
CH (1) CH677795A5 (en)
DE (1) DE3910667A1 (en)
DK (1) DK171489A (en)
ES (1) ES2013431A6 (en)
FR (1) FR2629824B1 (en)
GB (1) GB2224280B (en)
IL (1) IL89897A0 (en)
IT (1) IT1231943B (en)
LU (1) LU87496A1 (en)
NL (1) NL8900882A (en)
SE (1) SE8901278L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE284413T1 (en) * 1993-08-09 2004-12-15 Sod Conseils Rech Applic THERAPEUTIC PEPTIDE DERIVATIVES
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139526A (en) * 1977-12-01 1979-02-13 Merck & Co., Inc. Somatostatin analogs
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
JPH085913B2 (en) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド Therapeutic somatostatin congeners
HU906341D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance

Also Published As

Publication number Publication date
IT1231943B (en) 1992-01-16
DE3910667A1 (en) 1989-10-19
SE8901278D0 (en) 1989-04-10
NL8900882A (en) 1989-11-01
GB2224280A (en) 1990-05-02
FR2629824B1 (en) 1995-03-10
FR2629824A1 (en) 1989-10-13
BE1003200A4 (en) 1992-01-14
SE8901278L (en) 1989-10-12
JPH01305098A (en) 1989-12-08
LU87496A1 (en) 1989-11-14
GB2224280B (en) 1992-07-08
IL89897A0 (en) 1989-12-15
DK171489D0 (en) 1989-04-10
GB8907902D0 (en) 1989-05-24
AU3263989A (en) 1989-10-12
IT8947833A0 (en) 1989-04-10
DK171489A (en) 1989-10-12
CH677795A5 (en) 1991-06-28

Similar Documents

Publication Publication Date Title
MX9709278A (en) DIPEPTIDES THAT PROMOTE THE RELEASE OF GROWTH HORMONE, COMPOSITIONS THAT CONTAIN THEM AND USE THEM.
DK126389D0 (en) PEPTIDE COMPOUNDS
FR2385688A1 (en) NEW PEPTIDES WITH BIOLOGICAL ACTIVITY
RU94046306A (en) Derivatives of indolecarbazolimide, mixture of their isomers or the separate isomers and their salts and pharmaceutical composition showing activity inhibiting protein kinase c or kinase of the light myosin chain or immune reactions
ES527542A0 (en) A PROCEDURE FOR PREPARING NEW PEPTIDES
MY135057A (en) Dolastatin 15 derivatives
NO940299L (en) Peptide with organ protective activity
ES2121063T3 (en) DERIVATIVES OF BIPHENYL, ITS PREPARATION PROCEDURE AND ITS USE FOR THE TREATMENT OF HYPERTENSION AND HEART DISEASE.
TW200517400A (en) Antagonistic analogs of GH-RH (2003)
ES2010283A6 (en) Peptides
BG105638A (en) Antagonist analogs of gh-rh inhibiting igf-i and -ii
MY104979A (en) [ 5(6)(ih-azole-1-ylmethyl) benzimidazole] carbamates.
DK0752425T3 (en) Peptide ligands for the constant region on immunoglobulins
ES2013431A6 (en) PROCEDURE FOR PREPARING SOMATOSTATINE PEPTIDES.
AR004497A1 (en) AN ANALOGUE CYCLIC HEXAPEPTIDE OF SOMATOSTATINA, PROCEDURE TO PREPARE THEM AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF SUCH HEXAPEPTIDE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION.
ES553691A0 (en) PROCEDURE FOR OBTAINING A PEPTIDE.
GR3030856T3 (en) Use of somatostatin analogues for treating melanomas
ZA916918B (en) Amino acid analogs as CCK antagonists.
AR044852A1 (en) A PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION THAT INCLUDES A SOMATOSTATINE ANALOG
ES2112921T3 (en) PEPTIDES AND ANTIBODIES FOR THE TREATMENT OF RHEUMATOID ARTHRITIS.
DE69619530D1 (en) CYCLIC SOMATOSTATIN ANALOGS WITH GROWTH HUMOR INHIBITING ACTIVITY
BG102514A (en) New lh-rh-antagonists of improved effect
ES2052801T3 (en) DIASTEREOSELECTIVE PROCEDURE FOR THE PREPARATION OF USEFUL INTERMEDIARIES FOR THE SYNTHESIS OF PEPTIDIC DERIVATIVES.
ES2065855B1 (en) PROCEDURE FOR THE PREPARATION OF NEW DEOXIAZAPHOSPHOLIPIDIC DERIVATIVES WITH INHIBITING ACTION OF THE PHOSFOLIPASE A2, NEW DERIVATIVES DEOXIAZAPHOSPHOLIPIDICES OBTAINED AND USE OF THEM.
DE69715910D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDES FOR INHIBITING THE IMMUNOGLOBULIN RECEPTOR INTERACTION

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2009-04-11

FD1A Patent lapsed

Effective date: 20000201